3 dead due to hanmi pharmaceutical's lung cancer drug
Published 8 years ago • 305 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:51
hanmi signs diabetes license deal with sanofi for up to $4.2 billion 국내 당뇨 신약
-
0:45
korea's biosimilar drug market to nearly double by 2019
-
1:35
discovering and curing lung cancer in 3 weeks
-
0:47
korea's bio-health tech exports top 10 trillion won in 2015
-
2:30:57
3rd china-us anti-cancer summit 2023
-
0:49
hanmi pharmaceutical signs 3.9bn-euro license deal with sanofi / ytn
-
0:28
new virus cases in 500s for third straight day on friday amid vaccination push
-
2:16
s. korea releasing 3 patients after full recovery
-
6:20
drug-resistant ra: does blinatumomab bite?
-
15:53
patients' perspective | 3 women share about living with lymphoedema after breast cancer treatment
-
6:39
sar'579, a trifunctional anti-cd123 nk cell engager, in r/r aml, b-all, and hr-mds
-
2:01
korean researchers develop new non-invasive treatment for cancer
-
1:52
new ai technology detects more cancer patients treatable with immunotherapy
-
0:33
korean researchers find anti-cancer substance that selectively kills tumor cells
-
1:56
our heroes: mignon loh, md
-
2:48
new lung cancer test predicts survival
-
1:49
consumer spending on medical services up significantly in q3 after mers recovery
-
0:40
s. korea confirms 3,120 new covid-19 cases on sun. with more than 500 critically-ill patients
-
9:25
new antibody drug, mpdl3280a, in non-small cell lung cancer
-
2:01
current distancing measures extended for 3 more weeks: health authorities
-
2:09
the bull’s eye: new modified stem cells can deliver drugs specifically to tumor cells
-
1:51
new treatment strategy for patients with relapsed hematologic cancers